Medical News

RSS

New study challenges dopamine's role in placebo effects and pain relief

New findings argue against a direct causal role for dopamine during the experience of a treatment effect in the establishment of positive treatment expectations and placebo analgesia in healthy volunteers, according to a study published September 24th in the open-access journal PLOS Biology by Ulrike Bingel from University Hospital Essen, Germany, and colleagues.

24 Sep 2024

Research reveals key role of mucin modification in muco-obstructive diseases

With each breath, a human may inhale thousands of harmful microbes into the lungs. Mucus, the gel-like moist substance coating the airways, is one of the first lines of defense and aids in removal these microbes.

24 Sep 2024

California Governor signs law banning medical debt from credit reports

Californians with medical debt will no longer have to worry about unpaid medical bills showing up on their credit reports under legislation signed Tuesday by Gov. Gavin Newsom, adding the nation's most populous state to a growing effort to protect consumers squeezed by unaffordable medical bills.

24 Sep 2024

Study reveals sharp increase in micromobility vehicle-related injuries between 2019 and 2022

The rate of e-bike and powered scooter injuries surged between 2019 and 2022-- by 293 percent and 88 percent, respectively, according to a new study at Columbia University Mailman School of Public Health.

24 Sep 2024

Study links youth prediabetes to increased pregnancy risks later in life

New research conducted at Columbia Mailman School of Public Health and Mount Sinai School of Medicine shows a link between prediabetes among young people and adverse pregnancy outcomes later in life.

24 Sep 2024

New FDA award fuels research into autosomal dominant tubulointerstitial kidney disease

Critical Path Institute (C-Path) is thrilled to announce its Polycystic Kidney Disease Outcomes Consortium (PKDOC) has been awarded an Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) focused Broad Agency Announcement (BAA) contract from the U.S. Food and Drug Administration (FDA).

24 Sep 2024

New approach to B-ALL treatment reduces side effects and enhances survival

Clinical trial results from St. Jude Children's Research Hospital demonstrate benefits to using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL).

24 Sep 2024

New findings reveal how emotion enhances memory for contextual details

Researchers at the Beckman Institute for Advanced Science and Technology demonstrated that emotion enhances memory for contextual details, challenging the view that emotion impairs the ability to remember such information.

24 Sep 2024

Semaglutide shows promise in treating chronic skin condition in obese patients

A pioneering study, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.

24 Sep 2024

Global myopia prevalence among children and teens set to surpass 740 million by 2050

Around 1 in 3 children and teens around the world is short (near)-sighted, with the global prevalence of myopia set to top 740 million cases by 2050 in this age group, finds a pooled data analysis of the available evidence, published online in the British Journal of Ophthalmology.

24 Sep 2024

Music therapy improves sleep and comfort in preterm infants

Daily music interventions significantly improved comfort and sleep transitions in preterm infants without affecting physiological stability. This study highlights the potential of non-pharmacological music therapy in neonatal care.

24 Sep 2024

Targeted obesity programs reduce lipid-related heart disease risk in children

Researchers assess the lipid profiles of obese children and adolescents and their health implications.

24 Sep 2024

Study uncovers decision-making impairments linked to Parkinson's drug

Parkinson's disease (PD), also known simply as Parkinson's, is a disorder of the nervous system that affects millions of people worldwide.

24 Sep 2024

New Health Impact Investment Platform launches to strengthen primary care

Execution is starting under the new Health Impact Investment Platform on the first country health investment plans turning original commitment into operational reality.

24 Sep 2024

Study reveals limited access to opioid treatment in US jails

A new look into addiction treatment availability in the U.S. criminal justice system reveals that fewer than half (43.8%) of 1,028 jails surveyed across the nation offered any form of medication for opioid use disorder, and only 12.8% made these available to anyone with the disorder.

24 Sep 2024

New insights into how the brain processes the concept of zero

Despite its importance for mathematics, the neuronal basis of the number zero in the human brain was previously unknown.

24 Sep 2024

New guidelines for cardiovascular management in noncardiac surgery released

The 2024 guideline for cardiovascular management of adults undergoing noncardiac surgery reflects a decade of updates and new evidence since the guideline's last release in 2014.

24 Sep 2024

Nepalese women in Japan face challenges in accessing sexual and reproductive health services

Despite a substantial Nepalese community in Japan many Nepalese women face significant challenges in accessing essential sexual and reproductive health services (SRHSs) due to language barriers and differences in healthcare laws and services between Nepal and Japan.

24 Sep 2024

Study shows little rebound in cancer diagnoses post-pandemic

Cancer incidence trends in 2021 largely returned to what they were before the COVID-19 pandemic, according to a study by researchers at the National Institutes of Health (NIH).

24 Sep 2024

Innovative ALS study receives $22 million grant for experimental drug

Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic lateral sclerosis (ALS) access to the experimental drug ibudilast over six months.

24 Sep 2024